Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
about
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty AcidsA review of the management of antidepressant discontinuation symptomsInfluence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis.The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis.How do antidepressants work? New perspectives for refining future treatment approaches.Biomarkers for depression: recent insights, current challenges and future prospects.'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed dosesStudy protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medicationse-CBT (myCompass), Antidepressant Medication, and Face-to-Face Psychological Treatment for Depression in Australia: A Cost-Effectiveness Comparison.Lithium intoxication: Incidence, clinical course and renal function - a population-based retrospective cohort study.Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study.Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid.Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.Managing inadequate antidepressant response in depressive illness.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.Challenges Establishing the Efficacy of Exercise as an Antidepressant Treatment: A Systematic Review and Meta-Analysis of Control Group Responses in Exercise Randomised Controlled Trials.Neuropsychiatric sequelae of stroke.A critical review of exercise as a treatment for clinically depressed adults: time to get pragmatic.Pharmacotherapy of major depression in late life: what is the role of new agents?Antidepressant pharmacotherapy in old-age depression-a review and clinical approach.Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.Vagus nerve stimulation in psychiatry: a systematic review of the available evidence.Psychedelics in the treatment of unipolar mood disorders: a systematic review.Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.Brain grey matter volume alterations associated with antidepressant response in major depressive disorder.Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach.Clinical efficacy and economic evaluation of online cognitive behavioral therapy for major depressive disorder: a systematic review and meta-analysis.Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.
P2860
Q26740518-01A44D4B-274B-4119-A4C3-EE93EE3C0BA4Q26770373-91FA7AA6-3AEC-45FE-9133-300E104B3196Q26775107-0960D694-1B1A-4344-A46C-16455F74C21EQ31044175-F489031C-A1B2-49BF-985C-B078B5615C03Q31161297-8CA0FEA3-AD32-448A-9B05-A6D3897C9D4EQ33619029-D2022A5E-AB03-491D-9F37-4FE379477EF0Q33704099-E6D634F9-823E-4490-81C8-1C01862E601EQ33808307-B7A8F6BB-9DE5-4227-A1D3-022A7EABB341Q33837167-4CF6EF0E-538A-4797-9D18-F829ACF1C54BQ33863747-1C1E892A-C158-4BB8-82FD-0D9A72ABC7F0Q33879231-1505CA64-F492-4672-AC51-D300BEADC765Q34676317-A885CA14-FBFD-46AE-8F87-C68881692A37Q35862776-C6F1C2BA-780A-4394-9D2D-2EFC15B6EDDBQ36236193-F34FE415-2B28-4F83-8DBA-9193C75DF0C2Q36279100-E6D4E8D5-5691-4E06-BB06-82B75D354235Q36441195-F27526C8-505E-49B8-BFE8-589BCA592FDAQ37282083-A2F199D8-98DA-43A5-BAFB-F9826D5C5F6DQ37578354-7DC7405E-08C8-44A7-AD8B-C93C8CBBB43BQ37707350-9C996F2B-45BA-44AD-A8C1-84121224CB5FQ38374198-17AACBBD-BD4B-403F-A0E8-E0609840B330Q38574699-233226BA-4FD7-42FF-B41E-A3B74BCC4C4FQ38599005-C71ADDF5-AC14-45CB-A08A-907F28AB2693Q38680293-3E851F10-A7E6-4FBE-A7A5-311D1B892261Q38803780-BBFA6F7A-E43D-4C11-9439-9B498C789987Q38825607-10DF9130-EFB3-4DA9-A6B8-E3F3AD2FA35DQ38894956-98C80BC1-198E-4467-AD92-DF7E9A3E4794Q38915706-052140C0-EB30-41ED-95DE-ECC8A20C9406Q38939633-C315EB8B-78D9-4AEC-94DA-88B51ADB8033Q39009743-E97328C1-91A4-46C9-B7E8-D8A31E221791Q39011321-E78343C3-2EDC-4652-BF6C-2F71D186A00CQ39427310-3285D089-B52C-4F4F-99E6-245673EEB22CQ39486514-D9F9E8BB-DAB4-438B-B907-01840161A9C3Q40781394-379FA52F-1B62-42B8-B993-32528D11D782Q41620947-73107BE5-DE40-42C3-98E1-5ED44E3343B4Q41684438-2280FA62-9AA9-46FD-8BA2-3FF3AF5C487CQ46111793-242F4831-ECEF-41DA-ABC3-62A96BCDA1DAQ46466970-40F09735-E2D2-4F70-BE27-107A792B449EQ47097276-9BEB8ADE-81F5-4E2A-B158-28AC282D6AF9Q47573692-F9F59CBA-DEDF-4B7D-8679-245D8039911EQ47604739-C7F1BD0D-DDBF-41C6-9BAC-1A306E27FE1D
P2860
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evidence-based guidelines for ...... Psychopharmacology guidelines.
@en
type
label
Evidence-based guidelines for ...... Psychopharmacology guidelines.
@en
prefLabel
Evidence-based guidelines for ...... Psychopharmacology guidelines.
@en
P2093
P2860
P50
P356
P1476
Evidence-based guidelines for ...... Psychopharmacology guidelines
@en
P2093
Anthony Cleare
D Christmas
I N Ferrier
Members of the Consensus Meeting
P M Haddad
P Ramchandani
P2860
P304
P356
10.1177/0269881115581093
P407
P50
P577
2015-05-12T00:00:00Z